-
beta-cells, aiming to identify therapeutic targets for beta-cell regeneration in diabetes. Work with mouse and human cells, mouse models, and stem cells in the context of diabetes, utilizing techniques
-
epidemiology, innovative sequencing and bioinformatics technologies including single cell and spatial transcriptomics, molecular biology approaches using cell-based and animal models, and biomarker studies from
-
qualifications should include: PhD or M.D. with a strong background and profound knowledge in molecular biology, cancer biology, and metabolism. Previous experience in working with animal models of human cancers
-
utilizes genetic mouse models, molecular biology, imaging and epigenetic techniques to study the cellular identity, function, remodeling, and survival of beta-cells in physiological and pathological
-
cancer prevention and control education; increase awareness and utilization of resources; and increase community participation in health and biomedical research. Our model is a community participatory
-
. The project involves both in vitro and in vivo studies to uncover the molecular and cellular mechanisms driving cancer-associated immunosuppression using mouse and human solid tumor models. Additionally
-
or protein structural data analysis is highly preferred. Background with pharmacology, cell therapy or antibody engineering is also desired. · Previous experience in working with animal models
-
vivo immunogenicity and protective efficacy in different animal tumor models leading to early phase clinical trials in pancreas, lung, and bladder tumor patients. The goal of these efforts is a start-up
-
cancer. Work in the lab utilizes both genetically engineered mouse models and in vitro systems. A combination of state-of-the-art surgical, genetic, cellular, biochemical, imaging, and metabolic flux